Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Russia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20077
20082
20091
20131
20195
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Solvay Pharmaceuticals4
AbbVie3
Theravance Biopharma3
ACADIA Pharmaceuticals Inc.1
AbbVie (prior sponsor, Abbott)1
GlaxoSmithKline1
NeuroDerm Ltd.1
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease19
Dizziness3
Hypotension3
Pure Autonomic Failure3
Syncope3
Dyskinesias2
Hypotension, Orthostatic2
Parkinsonian Disorders2
Amyotrophic Lateral Sclerosis1
Multiple System Atrophy1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.